Biotechnology Reagents Market Report 2026

Biotechnology Reagents Market Report 2026
Global Outlook – By Type (Life Science Reagents, Analytical Reagents, Other Reagents), By Applications (Protein synthesis And purification, Gene Expression, DNA And RNA Analysis, Drug Testing), By End-Users (Biotech Companies, Research Institutes, Pharmaceuticals, Diagnostic Centers, Academic Institute, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035
Biotechnology Reagents Market Overview
• Biotechnology Reagents market size has reached to $92.14 billion in 2025 • Expected to grow to $148.21 billion in 2030 at a compound annual growth rate (CAGR) of 10% • Growth Driver: Biotechnology Reagents Market Surges With The Soaring Demand For Polymerase Chain Reaction (PCR) • Market Trend: Product Innovation In Reagent Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Biotechnology Reagents Market?
Biotechnology reagents refer to chemical compounds that are used in detecting, measuring, and preparing a product, and others by facilitating chemical. Biotechnology reagents are used in the quantification and detection of desired substances, as the binding of reagents to the substance or other related substances triggers certain reactions. The main types of biotechnology reagents are life science reagents, analytical reagents, and other reagents. Life science reagents refer to the substances used in a chemical reaction to observe the data record changes and to analyze this data to determine the cause of a disease. It is used in various applications such as protein synthesis and purification, gene expression, DNA and RNA analysis, and drug testing. The various end-users include biotech companies, research institutes, pharmaceuticals, diagnostic centers, academic institutes, and other end-users.
What Is The Biotechnology Reagents Market Size and Share 2026?
The biotechnology reagents market size has grown strongly in recent years. It will grow from $92.14 billion in 2025 to $101.21 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to expansion of biotechnology research activities, growth in pharmaceutical R&D spending, increasing adoption of molecular diagnostics, rising academic research funding, availability of advanced laboratory infrastructure.What Is The Biotechnology Reagents Market Growth Forecast?
The biotechnology reagents market size is expected to see rapid growth in the next few years. It will grow to $148.21 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, expansion of genomics and proteomics research, rising investments in personalized medicine, growing adoption of automated lab systems, increasing focus on reproducibility in research. Major trends in the forecast period include increasing demand for high-purity molecular biology reagents, rising adoption of advanced analytical reagents, growing use of pcr and gene expression kits, expansion of automated laboratory workflows, enhanced focus on reagent consistency and accuracy.Global Biotechnology Reagents Market Segmentation
1) By Type: Life Science Reagents, Analytical Reagents, Other Reagents 2) By Applications: Protein synthesis And purification, Gene Expression, DNA And RNA Analysis, Drug Testing 3) By End-Users: Biotech Companies, Research Institutes, Pharmaceuticals, Diagnostic Centers, Academic Institute, Other End-Users Subsegments: 1) By Life Science Reagents: Molecular Biology Reagents, Cell Culture Reagents, PCR Reagents, Protein Purification Reagents 2) By Analytical Reagents: Chromatography Reagents, Spectroscopy Reagents, Electrophoresis Reagents 3) By Other Reagents: Diagnostic Reagents, Biochemical Reagents, Enzyme ReagentsWhat Is The Driver Of The Biotechnology Reagents Market?
The rising demand for polymerase chain reaction (PCR) is expected to propel the growth of the biotechnology reagents market going forward. Polymerase chain reaction (PCR) refers to the molecular technique that is used to amplify smaller segments of DNA into large segments used to diagnose certain infectious diseases and study genetic changes. In polymerase chain reaction (PCR), biotechnology reagents are used to maintain a stable pH during the PCR process to ensure proper DNA synthesis function, which can later be used for various genomic studies and diagnosis purposes. For instance, in March 2025, according to the World Health Organization, a Switzerland-based United Nations specialized agency responsible for international public health, reported that during the four-week reporting period (6 January to 2 February 2025), weekly SARS-CoV-2 PCR positivity conducted through systematic virological surveillance changed from 7.3% in the first week of the reporting period to 5.0% in the last week, with a weekly average of over 69,900 specimens tested across 103 countries. Therefore, the rising demand for polymerase chain reaction (PCR) is driving the growth of the biotechnology reagents industry.Key Players In The Global Biotechnology Reagents Market
Major companies operating in the biotechnology reagents market are Life Technologies Corporation, Abbott Laboratories, Abcam PLC, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Company, BioLegend Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology, Danaher Corp., General Electric incorporated, Hoefer Inc., Illumina Inc., Lonza Group Ltd., Merck KGaA Group, Meridian Bioscience Inc., Millipore Corporation, New England Biolabs Inc., Novus Biologicals LLC, PerkinElmer Inc., Promega Corporation, Quality Biological Inc., Roche Holding AG, Siemens Healthineers AG, Sigma-Aldrich Corp., Sysmex Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Tosoh CorporationGlobal Biotechnology Reagents Market Trends and Insights
Major companies operating in the biotechnology reagent market are focusing on product innovation to strengthen their position in the industry. Product innovation involves developing new or improved biotechnology reagents that enhance research capabilities, diagnostic accuracy, or analytical performance. For instance, in May 2023, Bio-Techne, a global life sciences company that develops, manufactures, and sells life science reagents, announced the launch of two new RNAscope in situ Hybridization Probes, Kappa and Lambda, as analyte-specific reagents (ASRs). These probes are biotechnology reagents designed for the detection of immunoglobulin kappa and lambda light chain mRNA in B-cells, offering a significant advancement for both research and clinical diagnostic applications. This innovation supports improved molecular detection and expands capabilities for the research and clinical diagnostic communities.What Are Latest Mergers And Acquisitions In The Biotechnology Reagents Market?
In December 2023, Danaher Corporation, a US-based provider of life sciences instruments, reagents, and consumables for biotechnology and diagnostics applications, acquired Abcam plc for an undisclosed amount. With this acquisition, Danaher aims to strengthen its biotechnology reagents portfolio, enhance its global reach in life-science research and diagnostics, and accelerate innovation in reagent development for biopharmaceutical and academic markets. Abcam plc is a UK-based provider of research antibodies, proteins, and reagent kits used in biotechnology, molecular biology, and diagnostic applications.Regional Outlook
North America was the largest region in the biotechnology reagents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Biotechnology Reagents Market?
The biotechnology reagents market includes revenues earned by entities by chromatography, in-vitro diagnostics, polymerase chain reaction and cell culture technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Biotechnology Reagents Market Report 2026?
The biotechnology reagents market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology reagents industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Biotechnology Reagents Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $101.21 billion |
| Revenue Forecast In 2035 | $148.21 billion |
| Growth Rate | CAGR of 9.8% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Applications, End-Users |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Life Technologies Corporation, Abbott Laboratories, Abcam PLC, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Company, BioLegend Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology, Danaher Corp., General Electric incorporated, Hoefer Inc., Illumina Inc., Lonza Group Ltd., Merck KGaA Group, Meridian Bioscience Inc., Millipore Corporation, New England Biolabs Inc., Novus Biologicals LLC, PerkinElmer Inc., Promega Corporation, Quality Biological Inc., Roche Holding AG, Siemens Healthineers AG, Sigma-Aldrich Corp., Sysmex Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Tosoh Corporation |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Biotechnology Reagents market was valued at $92.14 billion in 2025, increased to $101.21 billion in 2026, and is projected to reach $148.21 billion by 2030.
request a sample hereThe global Biotechnology Reagents market is expected to grow at a CAGR of 10.0% from 2026 to 2035 to reach $148.21 billion by 2035.
request a sample hereSome Key Players in the Biotechnology Reagents market Include, Life Technologies Corporation, Abbott Laboratories, Abcam PLC, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Company, BioLegend Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology, Danaher Corp., General Electric incorporated, Hoefer Inc., Illumina Inc., Lonza Group Ltd., Merck KGaA Group, Meridian Bioscience Inc., Millipore Corporation, New England Biolabs Inc., Novus Biologicals LLC, PerkinElmer Inc., Promega Corporation, Quality Biological Inc., Roche Holding AG, Siemens Healthineers AG, Sigma-Aldrich Corp., Sysmex Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Tosoh Corporation .
request a sample hereMajor trend in this market includes: Product Innovation In Reagent Market. For further insights on this market.
request a sample hereNorth America was the largest region in the biotechnology reagents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here